Other very significant – and not so well known – partners of MYC in breast and uterus carcinomas include NDRG1, whose deficiency induces the epithelial-mesenchymal transition [49], CARM1, a methyltransferase known to methylate NOTCH1 [50], DDX5, a key mediator in the inhibition of ribosomal biogenesis by CDKN2A [51], and ZFP36L1, a regulator of apoptosis [52]. The gene discussed is CDKN2A; the disease is uterine carcinoma.